Slovenian Press Considers Consequences of Selling Lek
Ljubljana, 28 August - Commentaries of leading Slovenian dailies suggest that the sale of Slovenian pharmaceutical company Lek to Switzerland's Novartis should be viewed pragmatically, without reigniting the debate on the national interest. This will ultimately be the decision of the capital, Delo and Dnevnik agree.
The rest of this news item is available to subscribers.
The news item consists of 2.042 characters (without spaces) or 419 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.